Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
BMC Res Notes ; 2: 198, 2009 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-19785762

RESUMEN

BACKGROUND: The Copper/Zinc superoxide dismutase (Cu/ZnSOD) gene, SOD gene, was isolated from a Deschampsia antarctica Desv. by cDNA library screening. The expression of SOD gene in the leaves of D. antarctica was determined by RT-PCR and its differential expression of gene transcripts in conditions of cold and UV radiation stresses was revealed by northern blot. FINDINGS: The molecular characterization shows that SOD cDNA is 709 bp in length, which translates an ORF of 152 amino acids that correspond to a protein of predicted molecular mass of 15 kDa. The assay shows that the expression of SOD gene increases when D. antarctica is acclimatised to 4 degrees C and exposed to UV radiation. These results indicate that the SOD gene of D. antarctica is involved in the antioxidative process triggered by oxidative stress induced by the conditions of environmental change in which they live. CONCLUSION: The present results allow us to know the characteristics of Cu/ZnSOD gene from D. antarctica and understand that its expression is regulated by cold and UV radiation.

2.
BMC Res Notes ; 2: 207, 2009 Oct 12.
Artículo en Inglés | MEDLINE | ID: mdl-19821975

RESUMEN

BACKGROUND: Deschampsia antarctica shows tolerance to extreme environmental factors such as low temperature, high light intensity and an increasing UV radiation as result of the Antarctic ozone layer thinning. It is very likely that the survival of this species is due to the expression of genes that enable it to tolerate high levels of oxidative stress. On that account, we planned to clone the D. antarctica Cu/ZnSOD gene into Pichia pastoris and to characterize the heterologous protein. FINDINGS: The Copper/Zinc superoxide dismutase (Cu/ZnSOD) gene, SOD gene, was isolated from a D. antarctica by cDNA library screening. This SOD gene was cloned in the expression vector pGAPZalphaA and successfully integrated into the genome of the yeast P. pastoris SMD1168H. A constitutive expression system for the expression of the recombinant SOD protein was used. The recombinant protein was secreted into the YPD culture medium as a glycosylated protein with a 32 mg/l expression yield. The purified recombinant protein possesses a specific activity of 440 U/mg. CONCLUSION: D. antarctica Cu/ZnSOD recombinant protein was expressed in a constitutive system, and purified in a single step by means of an affinity column. The recombinant SOD was secreted to the culture medium as a glycoprotein, corresponding to approximately 13% of the total secreted protein. The recombinant protein Cu/ZnSOD maintains 60% of its activity after incubation at 40 degrees C for 30 minutes and it is stable (80% of activity) between -20 degrees C and 20 degrees C. The recombinant SOD described in this study can be used in various biotechnological applications.

3.
Rev. méd. Inst. Peru. Segur. Soc ; 2(3): 11-20, jul.-sept. 1993. ilus
Artículo en Español | LILACS | ID: lil-163569

RESUMEN

Se investigaron anticuerpos fijadores del complemento frente a los antígenos de Histoplasma Capsulatum, en el suero de 72 pacientes con síndrome respiratorio agudo y crónico, con signos anormales en radiografía de tórax, baciloscopía negativa y tratamiento antituberculoso. Resultaron 6 (8 por ciento) fijadores del complemento,, 6 (8 por ciento) anticomplementarios y 60 (84 por ciento) negativos. Dos pacientes mostraron títulos ò 1:4 frentes al antígeno micelial (AgM) y negativo al antígeno levaduriforme (AgL) y 4 pacientes mostraron títulos ó 1:8, frente a los dos antígenos. Un caso fue considerado como posible histoplasmosis "altamente sugestivo" y otro como histoplasmosis diseminada con evidencial histopatológica y cultural de histoplasmosis extrapulmonar. La edad de los pacientes de sueros positivos varió de 20-49 años y todos residieron temporalmente en zonas endémicas. Se comenta la utilidad clínica de los resultados y pruebas serológicas comunes.


Asunto(s)
Humanos , Proteínas del Sistema Complemento/inmunología , Proteínas del Sistema Complemento , Histoplasmosis/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA